PRESS RELEASE
21 October 2021

Uncover Risk Disclosures For Gene Therapies

MF
Morrison & Foerster LLP

Contributor

Known for providing cutting-edge legal advice on matters that are redefining industries, Morrison & Foerster has 17 offices located in the United States, Asia, and Europe. Our clients include Fortune 100 companies, leading tech and life sciences companies, and some of the largest financial institutions. We also represent investment funds and startups.
Join MoFo attorneys Brigid Bondoc and Erik Olson along with Advanced Cell & Gene Therapy principal Dr. Scott Burger during the 2021 Rare Disease Innovation & Partnering Summit.
United States

09 Dec 2021 10:55 a.m. - 11:40 a.m.

REGISTER

Join MoFo attorneys Brigid Bondoc and Erik Olson along with Advanced Cell & Gene Therapy principal Dr. Scott Burger during the 2021 Rare Disease Innovation & Partnering Summit. Participants of this virtual webinar will:

  • Outline the risks of gene therapy and how they have changed over the years as the science has improved
  • Discover how the SEC thinks about risk disclosure, particularly in a situation where the risk isn't just money
  • Discuss the FDA's role in controlling risk and balancing against benefits and cooperation with SEC
  • Explore shareholder litigation
  • Hear case studies
PRESS RELEASE
21 October 2021

Uncover Risk Disclosures For Gene Therapies

United States

Contributor

Known for providing cutting-edge legal advice on matters that are redefining industries, Morrison & Foerster has 17 offices located in the United States, Asia, and Europe. Our clients include Fortune 100 companies, leading tech and life sciences companies, and some of the largest financial institutions. We also represent investment funds and startups.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More